Immuron
IMRN
5 hedge funds and large institutions have $428K invested in Immuron in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0.01% less ownership
Funds ownership: 0.1% → 0.09% (-0.01%)
29% less funds holding
Funds holding: 7 → 5 (-2)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
70% less capital invested
Capital invested by funds: $1.4M → $428K (-$976K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.07K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$97.8K |
| 2 |
SPIA
Steward Partners Investment Advisory
New York
|
-$12K |
| 3 |
Renaissance Technologies
New York
|
-$1.88K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1K |
IMRN Hedge Fund Activity: Q2 2021 in Review
5 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Immuron (IMRN) for Q2 2021, worth a combined $428K — down 70% from $1.4M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of IMRN and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $1.07K. The largest seller was Morgan Stanley, cutting an estimated $97.8K.
- 5 institutional investors held Immuron (IMRN) as of Q2 2021, down from 7 in Q1 2021.
- Funds reported $428K of Immuron stock for Q2 2021, down 70% quarter-over-quarter.
- 0 funds opened new Immuron positions in Q2 2021 and 2 closed out, a net change of -2 holders.
- The largest Immuron buyer in Q2 2021 was UBS Group, an estimated $1.07K added.
- The largest Immuron seller in Q2 2021 was Morgan Stanley, an estimated $97.8K sold.
Based on aggregated 13F filings for Q2 2021.